EKF

UK-based EKF Diagnostics will launch two new diagnostic tests, a new assay for early sepsis detection and a hand-held point of care haemoglobin analyser at Medica 2014.

Medica 2014 will be held from 12-15 November in Düsseldorf, Germany.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The new CE Marked liquicolor procalcitonin (PCT) liquid-stable assay will be used on automatic chemistry analysers as an early and specific indicator of sepsis.

The PCT can be used to quickly evaluate the initial severity of sepsis, since procalcitonin levels elevate during systemic bacterial infection and sepsis.

Available in a liquid stable format, the new liquicolor PCT immunoturbidimetric assay can remain stable on-board a clinical chemistry analyser for four weeks, and requires a minimal sample of 20µl.

“The PCT can be used to quickly evaluate the initial severity of sepsis, since procalcitonin levels elevate during systemic bacterial infection and sepsis.”

According to the company, this assay also improves laboratory workflow as it can be run on a primary chemistry analyser and eliminate the need to split a sample.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

A new version of its Hemo Control haemoglobin analyser, the Biosen glucose and lactate analyser will be exhibited by the company, and includes the preview of SensPoint, a new lactate analyser designed for use in professional medical settings.

The company will also exhibit the new which can be used in all climate conditions.

DiaSpect uses reagent-free microcuvettes, which have a shelf-life of two and a half years, and can be stored from 0°-50°C.

The company said that DiaSpect is portable and lightweight and holds a long battery life for 40 days of continuous use, or 10,000 tests, due to its integrated rechargeable lithium-ion battery.

DiaSpect is factory calibrated against the HiCN reference method in accordance with International Council for Standardization in Haematology (ICSH) and requires no re-calibration or maintenance, as it undertakes an automatic self-check between every measurement.

Image: EKF DiaSpect Tm hemoglobin analyzer. Photo: courtesy of EKF Diagnostics.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact